Literature DB >> 11161975

IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic Islets.

M Falcone1, B Yeung, L Tucker, E Rodriguez, T Krahl, N Sarvetnick.   

Abstract

Several findings have recently questioned the long held hypothesis that cytokines belonging to the Th2 pathway are protective in T-cell-mediated autoimmunity. Among them, there is our previous report that pancreatic expression of IL-4 activated islet antigen-specific BDC2.5 T cells and rendered them able to trigger insulin-dependent diabetes mellitus in ins-IL-4/BDC2.5 mice (Mueller et al., Immunity, 7, 1997). Here we analyze the mechanisms underlying IL-4-mediated activation of the self-reactive BDC2.5 T cells. IL-4 is mainly known as the Th2-driving cytokine. However, IL-4 is also critical for DC maturation and upregulation of antigen uptake and presentation by macrophages. In our model, we found that pancreatic expression of IL-4 activated self-reactive BDC2.5 T cells by increasing islet antigen presentation by macrophages and dendritic cells. IL-4 could have triggered self-antigen presentation within the pancreatic islets both by driving maturation of DC from a tolerizing to a priming state and by increasing self-antigen uptake by macrophages. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161975     DOI: 10.1006/clim.2000.4979

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  7 in total

1.  Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3.

Authors:  C Gysemans; E Van Etten; L Overbergh; A Verstuyf; M Waer; R Bouillon; C Mathieu
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

2.  Combinations of common chronic paediatric diseases deviate the immune response in diverging directions.

Authors:  L Nilsson; A Kivling; M Jalmelid; K Fälth Magnusson; M Faresjö
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

3.  Site-specific regulation of tissue dendritic cell function by granulocyte-macrophage colony-stimulating-factor.

Authors:  Joanne Lees; David Boam; Tanakorn Proungvitaya; Peter J Wood
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

4.  A new mechanism for inhalational priming: IL-4 bypasses innate immune signals.

Authors:  Anna M Dittrich; Hui-Chen Chen; Lan Xu; Patricia Ranney; Sean Connolly; Timur O Yarovinsky; H Kim Bottomly
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

5.  Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes.

Authors:  Marcia McDuffie; Nelly A Maybee; Susanna R Keller; Brian K Stevens; James C Garmey; Margaret A Morris; Elizabeth Kropf; Claudia Rival; Kaiwen Ma; Jeffrey D Carter; Sarah A Tersey; Craig S Nunemaker; Jerry L Nadler
Journal:  Diabetes       Date:  2007-10-16       Impact factor: 9.461

6.  Prevention of autoimmune diabetes by ectopic pancreatic β-cell expression of interleukin-35.

Authors:  Maria Bettini; Ashley H Castellaw; Greig P Lennon; Amanda R Burton; Dario A A Vignali
Journal:  Diabetes       Date:  2012-03-16       Impact factor: 9.461

Review 7.  Means, Motive, and Opportunity: Do Non-Islet-Reactive Infiltrating T Cells Contribute to Autoimmunity in Type 1 Diabetes?

Authors:  Teresa Rodriguez-Calvo; Gustaf Christoffersson; Christine Bender; Matthias G von Herrath; Roberto Mallone; Sally C Kent; Eddie A James
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.